// App-Quantinova.ai

2908-03 : ASPIRIN TREATMENT AND OUTCOMES AFTER PCI: RESULTS OF THE INTRACORONARY STENTING AND ANTITHROMBOTIC REGIMEN ASPIRIN AND PLATELET INHIBITION (ISAR-ASPI) REGISTRY

Researchers

Presenter

  • Katharina Mayer

Principal Investigators

  • Isabell Bernlochner

  • Siegmund Braun

  • Dirk Sibbing

  • Stefanie Schulz

  • Martin Orban

  • Tanja Morath

  • Lisena Cala

  • Petra Hoppmann

  • Heribert Schunkert

  • Laugwitz Karl-Ludwig

  • Adnan Kastrati

Medical Centers

  • Department of Cardiology, LMU Munchen, Munich, Germany

  • Technische Universitat Munchen, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim